Psych News Alert | GLP-1 receptor agonist (GLP-1)

FDA Asks Companies to Remove Suicide Risk Warning From GLP-1 RA Labels

1/15/26 1:26 PM

The Food and Drug Administration (FDA) this week requested that manufacturers of glucagon-like pepti...

Researchers Look to Unlock GLP-1 Drugs’ Potential in Psychiatry

6/4/25 4:00 PM

Researchers are exploring the potential of glucagon-like peptide 1 (GLP-1) receptor agonists to trea...

Semaglutide Linked to Lower Risk of Alzheimer’s Disease in Type 2 Diabetes

10/25/24 12:00 AM